These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
893 related articles for article (PubMed ID: 12539025)
1. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Khurshudian AV Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411 [TBL] [Abstract][Full Text] [Related]
3. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223 [TBL] [Abstract][Full Text] [Related]
4. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Cummins MJ; Papas A; Kammer GM; Fox PC Arthritis Rheum; 2003 Aug; 49(4):585-93. PubMed ID: 12910567 [TBL] [Abstract][Full Text] [Related]
7. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433 [TBL] [Abstract][Full Text] [Related]
8. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial. Alves MB; Motta AC; Messina WC; Migliari DA Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. Rhodus NL; Bereuter J J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169 [TBL] [Abstract][Full Text] [Related]
10. Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group. Ship JA; Fox PC; Michalek JE; Cummins MJ; Richards AB J Interferon Cytokine Res; 1999 Aug; 19(8):943-51. PubMed ID: 10476942 [TBL] [Abstract][Full Text] [Related]
11. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome. Erlichman M Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638 [TBL] [Abstract][Full Text] [Related]
12. A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome. Gibson J; Halliday JA; Ewert K; Robertson S Br Dent J; 2007 Apr; 202(7):E17; discussion 404-5. PubMed ID: 17273177 [TBL] [Abstract][Full Text] [Related]
13. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study. Fox RI; Dixon R; Guarrasi V; Krubel S Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study. Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277 [TBL] [Abstract][Full Text] [Related]
15. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome. Jorkjend L; Bergenholtz A; Johansson AK; Johansson A Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial. Sugai S; Takahashi H; Ohta S; Nishinarita M; Takei M; Sawada S; Yamaji K; Oka H; Umehara H; Koni I; Sugiyama E; Nishiyama S; Kawakami A Mod Rheumatol; 2009; 19(2):114-24. PubMed ID: 19089532 [TBL] [Abstract][Full Text] [Related]
17. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome. Rihl M; Ulbricht K; Schmidt RE; Witte T Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433 [TBL] [Abstract][Full Text] [Related]
18. Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients. Frost PM; Shirlaw PJ; Challacombe SJ; Fernandes-Naglik L; Walter JD; Ide M Oral Dis; 2006 Jan; 12(1):57-62. PubMed ID: 16390470 [TBL] [Abstract][Full Text] [Related]
19. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Dass S; Bowman SJ; Vital EM; Ikeda K; Pease CT; Hamburger J; Richards A; Rauz S; Emery P Ann Rheum Dis; 2008 Nov; 67(11):1541-4. PubMed ID: 18276741 [TBL] [Abstract][Full Text] [Related]
20. Treatment of xerostomia in patients with primary Sjögren's syndrome with sulfarlem. Schiødt M; Oxholm P; Jacobsen A Scand J Rheumatol Suppl; 1986; 61():250-2. PubMed ID: 3473639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]